Partner Content Partner Content The Problem of the Hyperprolific Author When It Comes to KOL... The dangers of hyper-prolific authors
Partner Content Partner Content Boosting the reach of your publications and data Publications meets innovation in 'Headline Video'
News Novo Nordisk gets FDA okay for Wegovy pill The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of its Wegovy pill.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.